Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116410136A reveals a high-yield organic acid catalyzed cyclization for quinoline derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel reductive amination route for bromhexine hydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN115340460B enables high-yield indole intermediate production with reduced time and enhanced supply chain reliability for global buyers.
Patent CN109651179B reveals a green air-oxidation route for 2-(2-aminobenzoyl)benzoic acid derivatives, offering high regioselectivity and cost reduction in API manufacturing.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN111848322B reveals a novel resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel catalyst-free N-methylation using formic acid and triethylamine in DMSO. High yields, broad substrate scope, suitable for industrial scale-up of fine chemicals.
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives offering mild conditions and high selectivity for pharmaceutical supply chains.
Novel patent CN106317060B offers a safer, high-yield route for Conivaptan HCl. Reduces toxic reagents and enhances supply chain reliability for pharmaceutical manufacturers.
Novel patent CN116768904B enables high-purity intermediate production with mild conditions and substantial supply chain efficiency improvements for global pharmaceutical manufacturing partners seeking reliable sourcing.
Novel patent CN120698921A enables noble-metal-free synthesis. Reduces cost and safety risks for pharmaceutical intermediate manufacturing supply chains.
Patent CN113735867B reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with significant cost and supply chain advantages.
Novel chiral phosphoric acid catalysis enables high-purity indoline pyrroles. Efficient synthesis reduces costs for anticancer pharmaceutical intermediates supply chains.
Patent CN104662008A reveals novel tetrazole deprotection for Angiotensin II receptor blockers. Achieve cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Patent CN102180794B details a mild, aqueous synthesis of nitrobenzenes from arylboronic acids, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with scalable supply chain reliability and cost efficiency.